ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.00%
US Dollar vs MXN
16.7623
-0.19%
Brent Oil
84.065
0.14%
Bitcoin
63,206.52
0.25%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Jaguar Health Inc (JAGX)

  7. Jaguar Health Inc (JAGX) Noticias

JAGX

Jaguar Health (JAGX)

Jaguar Health Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:JAGX
FechaHoraFuenteTítuloSímboloCompañía
08/03/202416:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAGXJaguar Health Inc
05/03/202406:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JAGXJaguar Health Inc
30/11/202307:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:JAGXJaguar Health Inc
14/11/202320:00PR Newswire (Canada)FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTSNASDAQ:JAGXJaguar Health Inc
21/09/202306:30PR Newswire (Canada)FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERUNASDAQ:JAGXJaguar Health Inc
14/08/202315:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAGXJaguar Health Inc
14/08/202315:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:JAGXJaguar Health Inc
01/06/202305:01Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:JAGXJaguar Health Inc
31/05/202316:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:JAGXJaguar Health Inc
19/05/202316:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JAGXJaguar Health Inc
19/05/202316:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JAGXJaguar Health Inc
16/05/202316:30Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:JAGXJaguar Health Inc
15/05/202316:11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:JAGXJaguar Health Inc
15/05/202307:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JAGXJaguar Health Inc
28/04/202315:42Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:JAGXJaguar Health Inc
14/02/202315:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JAGXJaguar Health Inc
10/01/202307:30PR Newswire (Canada)Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health IllnessesNASDAQ:JAGXJaguar Health Inc
16/12/202205:01Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:JAGXJaguar Health Inc
02/09/202211:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:JAGXJaguar Health Inc
26/08/202209:59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JAGXJaguar Health Inc
16/08/202215:32Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:JAGXJaguar Health Inc
09/06/202207:30PR Newswire (Canada)Filament Health and Jaguar Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health IndicationsNASDAQ:JAGXJaguar Health Inc
23/05/202207:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:JAGXJaguar Health Inc
11/03/202215:34Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JAGXJaguar Health Inc
10/12/202116:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:JAGXJaguar Health Inc
07/12/202116:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:JAGXJaguar Health Inc
22/11/202116:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:JAGXJaguar Health Inc
06/09/202101:04TipRanksJaguar Health Announces 1-for-3 Reverse Stock Split; Shares Drop 13.8%NASDAQ:JAGXJaguar Health Inc
16/08/202103:02TipRanksJaguar Health Q2 Results Miss Estimates; Shares Fall 6.8%NASDAQ:JAGXJaguar Health Inc
09/04/202115:07Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)NASDAQ:JAGXJaguar Health Inc
 Showing the most relevant articles for your search:NASDAQ:JAGX

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
NYSE
NKE
Nike
USOTC
BASFY
BASF (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
CVX
Chevron
NYSE
BAC
Bank of America
NYSE
DIS
Walt Disney
CCOM
US30
US 30
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados